David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.04% |
| 2 | Healthcare | 13.44% |
| 3 | Consumer Discretionary | 13.38% |
| 4 | Financials | 7.19% |
| 5 | Industrials | 6.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
AdvanSix
ASIX
$454M
| $24.1M | 0.03% |
843,765
+75,356
| +10% | +$2.29M |
|
627
Paycom
PAYC
$10.3B
| $24.1M | 0.03% |
127,319
+23,241
| +22% | +$3.78M |
|
628
JB Hunt Transport Services
JBHT
$24.4B
| $24.1M | 0.03% |
237,669
+203,926
| +604% | +$21.1M |
|
|
ONCE
629
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $24.1M | 0.03% |
211,371
-803,078
| -79% | -$59M |
|
630
Rambus
RMBS
$9.44B
| $24M | 0.03% |
2,296,998
+1,258,916
| +121% | +$12.1M |
|
631
Perdoceo Education
PRDO
$2.07B
| $23.9M | 0.03% |
1,449,260
+16,994
| +1% | +$245K |
|
632
American Eagle Outfitters
AEO
$2.83B
| $23.9M | 0.03% |
1,079,691
+268,716
| +33% | +$5.52M |
|
633
PUT
Petrobras
PBR
$120B
| $23.9M | 0.03% |
1,501,900
-2,427,900
| -62% | -$38.5M |
|
|
PXD
634
PUT
DELISTED
Pioneer Natural Resource Co.
PXD
| $23.9M | 0.03% |
156,900
-57,500
| -27% | -$8.12M |
|
|
MIME
635
DELISTED
Mimecast Limited
MIME
| $23.9M | 0.03% |
504,444
+441,457
| +701% | +$18.6M |
|
|
VAR
636
DELISTED
Varian Medical Systems, Inc.
VAR
| $23.9M | 0.03% |
168,454
-52,808
| -24% | -$6.93M |
|
637
CALL
W.W. Grainger
GWW
$62.3B
| $23.8M | 0.03% |
79,200
-6,300
| -7% | -$1.87M |
|
638
Curtiss-Wright
CW
$22.7B
| $23.8M | 0.03% |
209,940
+45,815
| +28% | +$5.22M |
|
639
Haemonetics
HAE
$4.93B
| $23.7M | 0.03% |
270,608
+31,037
| +13% | +$2.82M |
|
|
XYZ
640
CALL
Block Inc
XYZ
$48.9B
| $23.5M | 0.03% |
313,400
-786,600
| -72% | -$57M |
|
641
Sabre
SABR
$912M
| $23.5M | 0.03% |
1,096,488
-749,931
| -41% | -$16.6M |
|
642
Analog Devices
ADI
$181B
| $23.4M | 0.03% |
222,689
-173,785
| -44% | -$17.4M |
|
643
Williams-Sonoma
WSM
$28B
| $23.4M | 0.03% |
832,414
+798,018
| +2,320% | +$22M |
|
644
PUT
Northrop Grumman
NOC
$78B
| $23.4M | 0.03% |
86,700
+38,800
| +81% | +$10.6M |
|
|
EGOV
645
DELISTED
NIC Inc
EGOV
| $23.4M | 0.03% |
1,366,889
+145,612
| +12% | +$2.31M |
|
646
Adeia
ADEA
$2.9B
| $23.3M | 0.03% |
3,768,792
+902,528
| +31% | +$5.3M |
|
|
647
PUT
Starbucks
SBUX
$123B
| $23.3M | 0.03% |
313,300
-537,000
| -63% | -$36.9M |
|
648
Amkor Technology
AMKR
$11.9B
| $23.3M | 0.03% |
2,725,939
+28,410
| +1% | +$235K |
|
|
SIVB
649
DELISTED
SVB Financial Group
SIVB
| $23.1M | 0.03% |
103,928
+30,145
| +41% | +$7.02M |
|
650
Affiliated Managers Group
AMG
$9.28B
| $23M | 0.03% |
215,167
+12,287
| +6% | +$1.31M |
|
Similar funds
David Shaw's Q1 2019 Portfolio in Review
As of Q1 2019, David Shaw held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
David Shaw withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Lyft worth $159M.
- David Shaw's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- David Shaw added most to Pfizer in Q1 2019, an estimated $436M increase.
- David Shaw's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- David Shaw fully exited Shire pic in Q1 2019, selling an estimated $276M.
- David Shaw's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- David Shaw opened 447 new positions and closed 617 in Q1 2019.
- David Shaw's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.